表观遗传学市场－全球产业规模、份额、趋势、机会和预测，按产品和服务、技术、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球表观遗传学市场规模为18.6亿美元，预计到2030年将以8.17%的复合年增长率成长至29.8亿美元。表观遗传学研究的是在不改变DNA序列的情况下发生的基因表现可遗传变化，这些变化会影响基因的活化或沉默，进而影响细胞过程和疾病进展。该市场的成长主要受全球慢性疾病（尤其是癌症）盛行率上升的驱动，因为表观遗传修饰在癌症的发展和治疗反应中起着至关重要的作用。

主要市场驱动因素

全球癌症发病率和死亡率的不断攀升显着推动了表观遗传学市场的发展，因为表观遗传学改变在肿瘤发生和发展中发挥重要作用。表观遗传诊断和治疗为早期检测、预后和治疗策略提供了新的途径，满足了迫切的医疗需求。

主要市场挑战

先进的表观遗传学研究和诊断技术成本高昂，严重阻碍了全球表观遗传学市场的成长。这些巨额费用直接限制了小型研究机构和新兴医疗机构的准入，使它们无法投资必要的设备、专业人员和进行大规模临床试验。

主要市场趋势

表观遗传学在老化和长寿研究中的应用代表着一个巨大的发展领域，它超越了传统的以疾病为中心的模式，转而关注健康寿命的延长。表观遗传修饰日益被认为是老化过程和年龄相关疾病的根本驱动因素，这促使人们投入大量资源来研究调节这些变化的干预措施。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球表观遗传学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品及服务分类（试剂盒及试剂、酵素、仪器及配件、软体、服务）
  • 依技术分类（DNA甲基化、组蛋白甲基化、其他）
  • 按最终用户划分（学术和研究机构、製药公司和生物技术公司、合约研究组织、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美表观遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲表观遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区表观遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲表观遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲表观遗传学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球表观遗传学市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Abcam Limited
• Active Motif Inc
• Hologic, Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Qiagen NV
• Thermo Fisher Scientific Inc
• Novartis AG
• Element Biosciences
• Dovetail Genomics LLC

第十六章：策略建议

第17章调查会社について・免责事项

The Global Epigenetic Market, valued at USD 1.86 Billion in 2024, is projected to experience a CAGR of 8.17% to reach USD 2.98 Billion by 2030. Epigenetics encompasses the study of heritable changes in gene expression that occur without altering the underlying DNA sequence, influencing how genes are activated or silenced to affect cellular processes and disease progression. The market's expansion is primarily driven by the increasing global prevalence of chronic diseases, particularly cancer, where epigenetic modifications play a crucial role in disease development and treatment response.

Key Market Drivers

The increasing burden of cancer incidence and mortality rates globally significantly drives the epigenetic market, given the established role of epigenetic alterations in tumorigenesis and progression. Epigenetic diagnostics and therapeutics offer novel avenues for early detection, prognosis, and treatment strategies, responding to an urgent unmet medical need.

Key Market Challenges

The substantial costs associated with advanced epigenetic research and diagnostic technologies pose a significant impediment to the global epigenetic market's growth. These considerable expenses directly limit accessibility for smaller research institutions and emerging healthcare providers, preventing them from investing in necessary equipment, specialized personnel, and extensive clinical trials. Such financial barriers restrict the widespread adoption of innovative epigenetic tools and therapies, particularly in regions with constrained healthcare budgets, thereby slowing overall market penetration and expansion.

Key Market Trends

The application of epigenetics in aging and longevity research represents a substantial area of growth, moving beyond traditional disease-centric models to focus on healthspan extension. Epigenetic modifications are increasingly recognized as fundamental drivers of the aging process and age-related conditions, prompting significant investment in interventions to modulate these changes.

Key Market Players

• Abcam Limited
• Active Motif Inc
• Hologic, Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Qiagen N.V.
• Thermo Fisher Scientific Inc
• Novartis AG
• Element Biosciences
• Dovetail Genomics LLC

Report Scope:

In this report, the Global Epigenetic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Epigenetic Market, By Product & Service:

• Kits & Reagents
• Enzymes
• Instruments & Accessories
• Software
• Services

Epigenetic Market, By Technology:

• DNA Methylation
• Histone Methylation
• Others

Epigenetic Market, By End user:

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations
• Others

Epigenetic Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Epigenetic Market.

Available Customizations:

Global Epigenetic Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Epigenetic Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Kits & Reagents, Enzymes, Instruments & Accessories, Software, Services)
  • 5.2.2. By Technology (DNA Methylation, Histone Methylation, Others)
  • 5.2.3. By End user (Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Epigenetic Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Service
  • 6.2.2. By Technology
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Epigenetic Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Service
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Epigenetic Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Service
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Epigenetic Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Service
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End user

7. Europe Epigenetic Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Service
  • 7.2.2. By Technology
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Epigenetic Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Service
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End user
  • 7.3.2. France Epigenetic Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Service
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Epigenetic Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Service
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Epigenetic Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Service
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Epigenetic Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Service
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End user

8. Asia Pacific Epigenetic Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Service
  • 8.2.2. By Technology
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Epigenetic Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Service
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End user
  • 8.3.2. India Epigenetic Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Service
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Epigenetic Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Service
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Epigenetic Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Service
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Epigenetic Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Service
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End user

9. Middle East & Africa Epigenetic Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Service
  • 9.2.2. By Technology
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Epigenetic Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Service
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Epigenetic Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Service
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Epigenetic Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Service
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End user

10. South America Epigenetic Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Service
  • 10.2.2. By Technology
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Epigenetic Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Service
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Epigenetic Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Service
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Epigenetic Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Service
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Epigenetic Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abcam Limited
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Active Motif Inc
• 15.3. Hologic, Inc.
• 15.4. F. Hoffmann-La Roche Ltd.
• 15.5. Illumina, Inc.
• 15.6. Qiagen N.V.
• 15.7. Thermo Fisher Scientific Inc
• 15.8. Novartis AG
• 15.9. Element Biosciences
• 15.10. Dovetail Genomics LLC

16. Strategic Recommendations

17. About Us & Disclaimer